{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:38:14Z","timestamp":1707525494001},"reference-count":33,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,24]]},"DOI":"10.7759\/cureus.49348","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T14:49:14Z","timestamp":1700837354000},"source":"Crossref","is-referenced-by-count":0,"title":["Bi-lineage B- and T-lymphoid Extramedullary Blast Crisis at an Initial Presentation of Chronic Myeloid Leukemia: A Case Report and Literature Review of Extramedullary Blast Crisis"],"prefix":"10.7759","author":[{"given":"Naoufal","family":"Benlachgar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azlarab","family":"Masrar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soukaina","family":"Haidouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hicham","family":"Harmouche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoubida","family":"Tazi Mezalek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Extramedullary disease in Ph\u2019-positive chronic myelogenous leukemia: frequency, clinical features and prognostic significance","volume":"75","author":"Inverardi D","year":"1990","unstructured":"Inverardi D, Lazzarino M, Morra E, et al.. Extramedullary disease in Ph\u2019-positive chronic myelogenous leukemia: frequency, clinical features and prognostic significance. Haematologica. 1990, 75:146-8.","journal-title":"Haematologica"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1309\/GTGTEQAFMV30W753","article-title":"Sudden extramedullary T-lymphoblastic blast crisis in chronic myelogenous leukemia: a nonrandom event associated with imatinib?","volume":"129","author":"Kim AS","year":"2008","unstructured":"Kim AS, Goldstein SC, Luger S, Van Deerlin VM, Bagg A. Sudden extramedullary T-lymphoblastic blast crisis in chronic myelogenous leukemia: a nonrandom event associated with imatinib?. Am J Clin Pathol. 2008, 129:639-48. 10.1309\/GTGTEQAFMV30W753","journal-title":"Am J Clin Pathol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1159\/000084448","article-title":"Philadelphia-chromosome-positive T-lymphoblastic leukemia: acute leukemia or chronic myelogenous leukemia blastic crisis","volume":"113","author":"Raanani P","year":"2005","unstructured":"Raanani P, Trakhtenbrot L, Rechavi G, et al.. Philadelphia-chromosome-positive T-lymphoblastic leukemia: acute leukemia or chronic myelogenous leukemia blastic crisis. Acta Haematol. 2005, 113:181-9. 10.1159\/000084448","journal-title":"Acta Haematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.600.600","article-title":"High incidence of mutated cancer-associated genes at diagnosis in CML patients with early transformation to blast crisis","volume":"126","author":"Branford S","year":"2015","unstructured":"Branford S, Wang PP, Parker WT, et al.. High incidence of mutated cancer-associated genes at diagnosis in CML patients with early transformation to blast crisis. Blood. 2015, 126:600. 10.1182\/blood.V126.23.600.600","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000046636","article-title":"Cytogenetic and molecular genetic evolution of chronic myeloid leukemia","volume":"107","author":"Johansson B","year":"2002","unstructured":"Johansson B, Fioretos T, Mitelman F. Cytogenetic and molecular genetic evolution of chronic myeloid leukemia. Acta Haematol. 2002, 107:76-94. 10.1159\/000046636","journal-title":"Acta Haematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2010.298","article-title":"A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases","volume":"25","author":"Grossmann V","year":"2011","unstructured":"Grossmann V, Kohlmann A, Zenger M, et al.. A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases. Leukemia. 2011, 25:557-60. 10.1038\/leu.2010.298","journal-title":"Leukemia"},{"key":"ref7","article-title":"Myeloproliferative disorders. Classification and diagnostic features with special emphasis on chronic myelogenous leukemia and agnogenic myeloid metaplasia","volume":"10","author":"Hyun BH","year":"1990","unstructured":"Hyun BH, Gulati GL, Ashton JK. Myeloproliferative disorders. Classification and diagnostic features with special emphasis on chronic myelogenous leukemia and agnogenic myeloid metaplasia. Clin Lab Med. 1990, 10:825-38.","journal-title":"Clin Lab Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20165","article-title":"Case of chronic-phase chronic myelogenous leukemia with an abdominal hematopoietic tumor of leukemic clone origin","volume":"77","author":"Sakakura M","year":"2004","unstructured":"Sakakura M, Ohishi K, Nomura K, et al.. Case of chronic-phase chronic myelogenous leukemia with an abdominal hematopoietic tumor of leukemic clone origin. Am J Hematol. 2004, 77:167-70. 10.1002\/ajh.20165","journal-title":"Am J Hematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2401606","article-title":"Ph-negative non-Hodgkin's lymphoma occurring in chronic phase of Ph-positive chronic myelogenous leukemia is defined as a genetically different neoplasm from extramedullary localized blast crisis: report of two cases and review of the literature","volume":"14","author":"Ichinohasama R","year":"2000","unstructured":"Ichinohasama R, Miura I, Takahashi N, et al.. Ph-negative non-Hodgkin's lymphoma occurring in chronic phase of Ph-positive chronic myelogenous leukemia is defined as a genetically different neoplasm from extramedullary localized blast crisis: report of two cases and review of the literature. Leukemia. 2000, 14:169-82. 10.1038\/sj.leu.2401606","journal-title":"Leukemia"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/dc.21795","article-title":"Fluorescent in situ hybridization diagnosis of extramedullary nodal blast crisis","volume":"41","author":"Jin GN","year":"2013","unstructured":"Jin GN, Zou P, Chen WX, Ding ZY, Zhou H. Fluorescent in situ hybridization diagnosis of extramedullary nodal blast crisis. Diagn Cytopathol. 2013, 41:253-6. 10.1002\/dc.21795","journal-title":"Diagn Cytopathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/10428194.2020.1855346","article-title":"Utility of 18F-FDG-PET\/CT in lymphoblastic lymphoma","volume":"62","author":"Fox TA","year":"2021","unstructured":"Fox TA, Carpenter B, Taj M, et al.. Utility of 18F-FDG-PET\/CT in lymphoblastic lymphoma. Leuk Lymphoma. 2021, 62:1010-2. 10.1080\/10428194.2020.1855346","journal-title":"Leuk Lymphoma"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/RLU.0b013e31817792a3","article-title":"Early response assessment in gastrointestinal stromal tumors with FDG PET scan 24 hours after a single dose of imatinib","volume":"33","author":"Shinto A","year":"2008","unstructured":"Shinto A, Nair N, Dutt A, Baghel NS. Early response assessment in gastrointestinal stromal tumors with FDG PET scan 24 hours after a single dose of imatinib. Clin Nucl Med. 2008, 33:486-7. 10.1097\/RLU.0b013e31817792a3","journal-title":"Clin Nucl Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2018.9447","article-title":"Analyses and treatment of simultaneous bi-lineage malignancies of myeloid leukemia and lymphoma: two case reports and a literature review","volume":"16","author":"Fu X","year":"2018","unstructured":"Fu X, Shang Y, Zhang L, et al.. Analyses and treatment of simultaneous bi-lineage malignancies of myeloid leukemia and lymphoma: two case reports and a literature review. Oncol Lett. 2018, 16:6624-32. 10.3892\/ol.2018.9447","journal-title":"Oncol Lett"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24579","article-title":"Clinical characteristics of Philadelphia positive T-cell lymphoid leukemias-(De novo and blast phase CML)","volume":"92","author":"Jain P","year":"2017","unstructured":"Jain P, Kantarjian H, Jabbour E, et al.. Clinical characteristics of Philadelphia positive T-cell lymphoid leukemias-(De novo and blast phase CML). Am J Hematol. 2017, 92:E3-4. 10.1002\/ajh.24579","journal-title":"Am J Hematol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7276128","article-title":"A rare case of chronic myelogenous leukemia presenting as T-cell lymphoblastic crisis","volume":"2018","author":"Padhi P","year":"2018","unstructured":"Padhi P, Topalovski M, El Behery R, Cantu ES, Medavarapu R. A rare case of chronic myelogenous leukemia presenting as T-cell lymphoblastic crisis. Case Rep Oncol Med. 2018, 2018:7276128. 10.1155\/2018\/7276128","journal-title":"Case Rep Oncol Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702665","article-title":"Extramedullary T cell lymphoblastic transformation of chronic myeloid leukaemia successfully treated with matched unrelated donor bone marrow transplantation","volume":"26","author":"Apfelbeck U","year":"2000","unstructured":"Apfelbeck U, Hoefler G, Neumeister P, Fonatsch C, Linkesch W, Sill H. Extramedullary T cell lymphoblastic transformation of chronic myeloid leukaemia successfully treated with matched unrelated donor bone marrow transplantation. Bone Marrow Transplant. 2000, 26:1111-2. 10.1038\/sj.bmt.1702665","journal-title":"Bone Marrow Transplant"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00542.x","article-title":"'Lymphoid' blast crisis of chronic myeloid leukaemia is associated with distinct clinicohaematological features","volume":"100","author":"Cervantes F","year":"1998","unstructured":"Cervantes F, Villamor N, Esteve J, Montoto S, Rives S, Rozman C, Montserrat E. 'Lymphoid' blast crisis of chronic myeloid leukaemia is associated with distinct clinicohaematological features. Br J Haematol. 1998, 100:123-8. 10.1046\/j.1365-2141.1998.00542.x","journal-title":"Br J Haematol"},{"key":"ref18","article-title":"Management of chronic myeloid leukaemia in lymphoid blast transformation","volume":"78","author":"18] Nathwani AC","year":"1993","unstructured":"18] Nathwani AC, Goldman JM. Management of chronic myeloid leukaemia in lymphoid blast transformation. Haematologica. 1993, 78:162-6.","journal-title":"Haematologica"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19990101)85:1<58::AID-CNCR8>3.0.CO;2-E","article-title":"Complete hematologic and cytogenetic response to 2-amino-9-beta-D-arabinosyl-6-methoxy-9H-guanine in a patient with chronic myelogenous leukemia in T-cell blastic phase: a case report and review of the literature","volume":"85","author":"Aguayo A","year":"1999","unstructured":"Aguayo A, Cortes JE, Kantarjian HM, et al.. Complete hematologic and cytogenetic response to 2-amino-9-beta-D-arabinosyl-6-methoxy-9H-guanine in a patient with chronic myelogenous leukemia in T-cell blastic phase: a case report and review of the literature. Cancer. 1999, 85:58-64. 10.1002\/(SICI)1097-0142(19990101)85:1&lt;58::AID-CNCR8&gt;3.0.CO;2-E","journal-title":"Cancer"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200104053441402","article-title":"Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome","volume":"344","author":"Druker BJ","year":"2001","unstructured":"Druker BJ, Sawyers CL, Kantarjian H, et al.. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med. 2001, 344:1038-42. 10.1056\/NEJM200104053441402","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v99.10.3547","article-title":"Imatinib mesylate (STI571) therapy for Philadelphia chromosome-positive chronic myelogenous leukemia in blast phase","volume":"99","author":"Kantarjian HM","year":"2002","unstructured":"Kantarjian HM, Cortes J, O'Brien S, et al.. Imatinib mesylate (STI571) therapy for Philadelphia chromosome-positive chronic myelogenous leukemia in blast phase. Blood. 2002, 99:3547-53. 10.1182\/blood.v99.10.3547","journal-title":"Blood"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2015.2173","article-title":"Extramedullary T-lymphoblastic blast crisis in chronic myelogenous leukemia: a case report of successful diagnosis and treatment","volume":"9","author":"Zeng DF","year":"2015","unstructured":"Zeng DF, Chang C, Li JP, Kong PY, Zhang X, Gao L. Extramedullary T-lymphoblastic blast crisis in chronic myelogenous leukemia: a case report of successful diagnosis and treatment. Exp Ther Med. 2015, 9:850-2. 10.3892\/etm.2015.2173","journal-title":"Exp Ther Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-03-380147","article-title":"How I treat CML blast crisis","volume":"120","author":"Hehlmann R","year":"2012","unstructured":"Hehlmann R. How I treat CML blast crisis. Blood. 2012, 120:737-47. 10.1182\/blood-2012-03-380147","journal-title":"Blood"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1306494","article-title":"A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias","volume":"369","author":"Cortes JE","year":"2013","unstructured":"Cortes JE, Kim DW, Pinilla-Ibarz J, et al.. A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias. N Engl J Med. 2013, 369:1783-96. 10.1056\/NEJMoa1306494","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-147972","article-title":"Ponatinib in combination with FLAG-IDA chemotherapy for blast-phase chronic myeloid leukemia: final results of the seamless phase I\/II dose-finding UK trials Acceleration Programme (TAP) matchpoint trial","volume":"138","author":"Copland M","year":"2021","unstructured":"Copland M, Slade D, McIlroy G, et al.. Ponatinib in combination with FLAG-IDA chemotherapy for blast-phase chronic myeloid leukemia: final results of the seamless phase I\/II dose-finding UK trials Acceleration Programme (TAP) matchpoint trial. Blood. 2021, 138:312-10. 10.1182\/blood-2021-147972","journal-title":"Blood"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-153795","article-title":"Updated results of a Phase II study of ponatinib and blinatumomab for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"138","author":"Short NJ","year":"2021","unstructured":"Short NJ, Kantarjian H, Konopleva M, et al.. Updated results of a Phase II study of ponatinib and blinatumomab for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood. 2021, 138:2298-2298. 10.1182\/blood-2021-153795","journal-title":"Blood"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26238","article-title":"Inotuzumab ozogamicin with bosutinib for relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia or lymphoid blast phase of chronic myeloid leukemia","volume":"96","author":"Jain N","year":"2021","unstructured":"Jain N, Maiti A, Ravandi F, et al.. Inotuzumab ozogamicin with bosutinib for relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia or lymphoid blast phase of chronic myeloid leukemia. Am J Hematol. 2021, 96:1000-7. 10.1002\/ajh.26238","journal-title":"Am J Hematol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1159\/000506346","article-title":"Venetoclax and Bcr-Abl tyrosine kinase inhibitor combinations: outcome in patients with Philadelphia chromosome-positive advanced myeloid leukemias","volume":"143","author":"Maiti A","year":"2020","unstructured":"Maiti A, Franquiz MJ, Ravandi F, et al.. Venetoclax and Bcr-Abl tyrosine kinase inhibitor combinations: outcome in patients with Philadelphia chromosome-positive advanced myeloid leukemias. Acta Haematol. 2020, 143:567-73. 10.1159\/000506346","journal-title":"Acta Haematol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2014.146","article-title":"Allogeneic hematopoietic SCT in combination with tyrosine kinase inhibitor treatment compared with TKI treatment alone in CML blast crisis","volume":"49","author":"Jiang H","year":"2014","unstructured":"Jiang H, Xu LP, Liu DH, et al.. Allogeneic hematopoietic SCT in combination with tyrosine kinase inhibitor treatment compared with TKI treatment alone in CML blast crisis. Bone Marrow Transplant. 2014, 49:1146-54. 10.1038\/bmt.2014.146","journal-title":"Bone Marrow Transplant"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000468","article-title":"Chronic myeloid leukemia in 2020","volume":"4","author":"Hehlmann R","year":"2020","unstructured":"Hehlmann R. Chronic myeloid leukemia in 2020. Hemasphere. 2020, 4:e468. 10.1097\/HS9.0000000000000468","journal-title":"Hemasphere"},{"key":"ref31","article-title":"Asciminib and ponatinib exert synergistic anti-neoplastic effects on CML cells expressing BCR-ABL1T315I-compound mutations","volume":"11","author":"Gleixner KV","year":"2021","unstructured":"Gleixner KV, Filik Y, Berger D, et al.. Asciminib and ponatinib exert synergistic anti-neoplastic effects on CML cells expressing BCR-ABL1T315I-compound mutations. Am J Cancer Res. 2021, 11:4470-84.","journal-title":"Am J Cancer Res"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2018.02.005","article-title":"Mixed phenotype (T\/B\/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia","volume":"104","author":"Qing X","year":"2018","unstructured":"Qing X, Qing A, Ji P, French SW, Mason H. Mixed phenotype (T\/B\/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia. Exp Mol Pathol. 2018, 104:130-3. 10.1016\/j.yexmp.2018.02.005","journal-title":"Exp Mol Pathol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/304359","article-title":"Unusual T-lymphoblastic blast phase of chronic myelogenous leukemia","volume":"2014","author":"Xu J","year":"2014","unstructured":"Xu J, Li S. Unusual T-lymphoblastic blast phase of chronic myelogenous leukemia. Case Rep Hematol. 2014, 2014:304359. 10.1155\/2014\/304359","journal-title":"Case Rep Hematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/188013-bi-lineage-b--and-t-lymphoid-extramedullary-blast-crisis-at-an-initial-presentation-of-chronic-myeloid-leukemia-a-case-report-and-literature-review-of-extramedullary-blast-crisis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:10:24Z","timestamp":1707509424000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/188013-bi-lineage-b--and-t-lymphoid-extramedullary-blast-crisis-at-an-initial-presentation-of-chronic-myeloid-leukemia-a-case-report-and-literature-review-of-extramedullary-blast-crisis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,24]]},"references-count":33,"URL":"https:\/\/doi.org\/10.7759\/cureus.49348","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,24]]}}}